명인제약
40,000KRWMarket close of 10/28 (Wed)
Down -0.50%-200KRWMarket close of 10/28 (Wed)
- Open
- 40,200
- High
- 40,650
- Low
- 39,900
- Day range
- Day range low 39,900 high 40,650, open 40,200, close 40,000, previous close 40,200
- Volume
- 2×10K shares
- 658.03 million KRW 1.45× the 20-session average
Market close of 10/28 (Wed)
Where it sits in the 1-year range
0%1-year close range 39,800 to 96,700 won, 0% up from the low
0% of the way up from the lowest close in 1 year (252 sessions) · -58.6% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-0.50%usual range
- Trading value1.5×usual range
See the full check report
Quarterly results · Q1 2026
- Revenue72.1B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating income25.1B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating margin34.8%
- vs. year ago
- —
- vs. prior quarter
- —
Quarterly operating income trend
As of the latest official close · 2026-10-28Valuation filing date · 2026-05-14Same sector · 제약
Up +0.44%· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +6.1% | Up +0.64% | 80.0B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -0.9% | Down -0.15% | 68.9B KRW |
| 파마리서치 | Close over the last 20 sessions -27.8% | Down -1.30% | 43.9B KRW |
| 한미약품 | Close over the last 20 sessions -27.1% | Up +5.42% | 42.3B KRW |
| 삼익제약 | Close over the last 20 sessions -13.1% | Up +9.54% | 34.5B KRW |
Schedule
- Next data 10/30 (Fri) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.